glp-1 optimization consultation maryland I'm often asked about medications, which isn't surprising given how widely they're now being discussed and offered. Many healthcare companies, practices, and clinicians have incorporated them into care, and during yesterday's The Hidden Dangers of GLP-1

Among the biggest firms, those with at least 5,000 workers, 43% now say they cover GLP-1 drugs for weight loss in their largest plan, up from 28% in 2024.

Work with your clinician to rule these out while evaluating gluten and nutrient status

Serum levels of CK-MB, AST, and cTnI were dramatically reduced after receiving 200 mg/kg l-carnitine for four weeks, which significantly reduced TRZ cardiotoxicity (Khedr et al

The LEADER trial demonstrated cardiovascular benefits with liraglutide 1.8 mg (Victoza) in patients with type 2 diabetes, but Saxenda (liraglutide 3.0 mg) is not indicated for cardiovascular risk reduction

For years, endocrine-resistant breast cancer with ESR1 mutations has been one of oncology's most stubborn challenges

Whey protein concentrate (WPC) was selected as a protein excipient and processed with a naturally occurring crosslinker